| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $13.95B | $13.44B | $10.78B | $4.80B | $1.64B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $12.39B | $11.38B | $9.33B | $5.14B | $2.48B |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | $1.56B | $2.06B | $1.44B | -$339.60M | -$839.40M |
| Interest Expense | $66.50M | $83.00M | $76.80M | $91.40M | $297.10M |
| Tax Expense | $172.80M | $210.90M | $128.70M | -$189.00M | -$93.60M |
| Net Income | $1.61B | $1.92B | $1.31B | -$240.80M | -$1.02B |
| EPS (basic) | 1.4631 | 1.6828 | 1.1557 | -0.2130 | -0.9142 |
| EPS (diluted) | 1.4549 | 1.6743 | 1.1529 | -0.2130 | -0.9142 |
| Shares (diluted) | $1.11B | $1.15B | $1.14B | $1.13B | $1.11B |